Skip to main content
Top
Published in: Journal of Community Health 6/2017

01-12-2017 | Original Paper

Factors Associated with HPV Vaccination in Young Males

Authors: Kelli M. Fuller, Leslie Hinyard

Published in: Journal of Community Health | Issue 6/2017

Login to get access

Abstract

Human papilloma virus (HPV) affects both men and women; however, recommendations for HPV vaccination among men were not issued in the United States until 2011. The purpose of this study was to describe and compare characteristics of men who did and did not report receiving at least one dose of the HPV vaccine. Data from the ten states that completed the HPV vaccination module in the 2013 Behavioral Risk Factor Surveillance System (BRFSS) were included in the study. Young men ages 18–26 were included (N = 1624). Categorical variables were compared between those who did and did not receive the HPV vaccine using Chi square. Logistic regression was used to examine the odds of HPV vaccination by the above factors. Only 16.5% of men reported at least one dose of HPV vaccine. Having health insurance, having a primary doctor, and receiving an HIV test were predictive of HPV vaccination. Men in Texas were more likely to report HPV vaccination than all other states. Overall, HPV vaccination is low in men. Targeted interventions for improving HPV vaccination rates in men are warranted, especially for those without health insurance or a routine source of care.
Literature
1.
go back to reference Anderson, M., Dobkin, C., & Gross, T. (2012). The effect of health insurance coverage on the use of medical services. American Economic Journal: Economic Policy, 4(1), 1–27. Anderson, M., Dobkin, C., & Gross, T. (2012). The effect of health insurance coverage on the use of medical services. American Economic Journal: Economic Policy, 4(1), 1–27.
3.
go back to reference Canepa, P., Orsi, M., Martini, M., & Icardi, G. (2013). HPV related diseases in males: A heavy vaccine-preventable burden. Journal of Preventative Medicine and Hygiene, 54(2), 61–70. Canepa, P., Orsi, M., Martini, M., & Icardi, G. (2013). HPV related diseases in males: A heavy vaccine-preventable burden. Journal of Preventative Medicine and Hygiene, 54(2), 61–70.
11.
go back to reference Cifu, A. S., & Davis, A. M. (2014). Use of HPV vaccine in males and females. JAMA, Clinical Guidelines Synopsis, 312(18), 1920–1921. Cifu, A. S., & Davis, A. M. (2014). Use of HPV vaccine in males and females. JAMA, Clinical Guidelines Synopsis, 312(18), 1920–1921.
13.
go back to reference Gerend, M. A., Shepherd, M. A., Lustria, M. L., & Shepherd, J. E. (2016). Predictors of provider recommendation for HPV vaccine among young adult men and women: Findings from a cross sectional survey, Sexually Transmitted Infections, 92, 104–107. doi:10.1136/sextrans-2015-052088.CrossRefPubMed Gerend, M. A., Shepherd, M. A., Lustria, M. L., & Shepherd, J. E. (2016). Predictors of provider recommendation for HPV vaccine among young adult men and women: Findings from a cross sectional survey, Sexually Transmitted Infections, 92, 104–107. doi:10.​1136/​sextrans-2015-052088.CrossRefPubMed
16.
go back to reference Kornfeld, J., Byrne, M. M., Vanderpool, R., Shin, S., & Kobetz, E. (2013). HPV knowledge and vaccine acceptability among Hispanic fathers. Journal of Primary Prevention, 34(1–2), 59–69.CrossRefPubMedPubMedCentral Kornfeld, J., Byrne, M. M., Vanderpool, R., Shin, S., & Kobetz, E. (2013). HPV knowledge and vaccine acceptability among Hispanic fathers. Journal of Primary Prevention, 34(1–2), 59–69.CrossRefPubMedPubMedCentral
18.
go back to reference Lu, P., Yankey, D., Jeyarajah, J., O’Halloran, A., Elam-Evans, L. D., Smith, P. J., Stokley, S., Singleton, J. A., & Dunne, E. F. (2015). HPV vaccination coverage of male adolescents in the United States. Pediatrics, 136(5), 839–849. doi:10.1542/peds.2015-1631.CrossRefPubMed Lu, P., Yankey, D., Jeyarajah, J., O’Halloran, A., Elam-Evans, L. D., Smith, P. J., Stokley, S., Singleton, J. A., & Dunne, E. F. (2015). HPV vaccination coverage of male adolescents in the United States. Pediatrics, 136(5), 839–849. doi:10.​1542/​peds.​2015-1631.CrossRefPubMed
19.
20.
go back to reference Petrosky, E., Bocchini, J. J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.PubMed Petrosky, E., Bocchini, J. J., Hariri, S., Chesson, H., Curtis, C. R., Saraiya, M., et al. (2015). Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report, 64(11), 300–304.PubMed
21.
25.
go back to reference Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., Curtis, R., & Markowirz, L. (2014). HPV vaccination coverage among adolescents, 2007–2013, and post-licensure vaccine safety monitoring, 2006–2014. Morbidity and Mortality Weekly Report, 63(29), 620–624.PubMed Stokley, S., Jeyarajah, J., Yankey, D., Cano, M., Gee, J., Roark, J., Curtis, R., & Markowirz, L. (2014). HPV vaccination coverage among adolescents, 2007–2013, and post-licensure vaccine safety monitoring, 2006–2014. Morbidity and Mortality Weekly Report, 63(29), 620–624.PubMed
Metadata
Title
Factors Associated with HPV Vaccination in Young Males
Authors
Kelli M. Fuller
Leslie Hinyard
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Community Health / Issue 6/2017
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-017-0361-4

Other articles of this Issue 6/2017

Journal of Community Health 6/2017 Go to the issue